New active analogues of vitamin D with low calcemic activity

Brown, A.J.; Finch, J.L.; Lopez-Hilker, S.; Dusso, A.; Ritter, C.; Pernalete, N.; Slatopolsky, E.

Kidney International. Suppl 29: S22-S27


ISSN/ISBN: 0098-6577
PMID: 2214544
Document Number: 366557
In conclusion, a number vitamin D analogues have been developed that have very low calcemic activity but retain several other properties of 1,25-(OH)2D3, including the ability to differentiate leukemia and skin cells, to enhance the immune response, and to suppress parathyroid hormone levels. Although the mechanism of this selective activity is not yet clear, these analogues may provide new insights into the differences in action of 1,25-(OH)2D3 in various target tissues. Most importantly, the selective action of these analogues may be exploited for the treatment of diseases such as leukemia, psoriasis and hyperparathyroidism.

Document emailed within 1 workday
Secure & encrypted payments